For the best outcome and restoration of trust, this completely independent group of researchers would analyze data (and preferably design) from an industry-linked clinical trial.

FORBES: How Can Big Pharma Restore A Reputation?

"It looks like we've got a drug that will finally be able to kill resistant staph better than our standard therapy, " says Ralph Corey of the Duke Clinical Research Institute, one of the outside doctors who helped analyze the data.

FORBES: The Next Antibiotic Buyout?